Ophthalmic Viscoelastic Devices Market Outlook Report 2023-2028

Ophthalmic Viscoelastic Devices Market

According to IMARC Group’s latest research report, titled “Ophthalmic Viscoelastic Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the ophthalmic viscoelastic devices market share. The report also includes competitor and regional analysis, and contemporary advancements in the market. The global ophthalmic viscoelastic devices (OVD) market size reached US$ 2.61 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.32 Billion by 2028, exhibiting a growth rate (CAGR) of 4.0% during 2023-2028.

Ophthalmic Viscoelastic Devices Market Outlook:

Ophthalmic Viscoelastic Devices (OVDs) are substances used in ophthalmic surgery to protect the eye’s delicate tissues and improve surgical outcomes. They are gel-like materials that can be injected into the eye to maintain its shape during surgery and then removed at the end of the procedure. OVDs can help protect the cornea and other delicate tissues of the eye from damage during surgery and provide a clear visual field for the surgeon. They can also help prevent complications such as inflammation, infection, and damage to the lens or retina. OVDs are typically made from hyaluronic acid, a natural substance found in the body, or from other synthetic materials. They come in different viscosities or thicknesses, depending on the specific needs of the surgery. OVDs are commonly used in cataract surgery, glaucoma surgery, and other ophthalmic procedures.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/ophthalmic-viscoelastic-devices-market/requestsample

Ophthalmic Viscoelastic Devices Market Trends:

The global market is majorly driven by the rising number of ophthalmic surgeries being performed worldwide. In line with this, the increasing prevalence of eye diseases such as cataracts, macular degeneration, and diabetic retinopathy is significantly contributing to the market growth. Furthermore, the growing geriatric population and escalating demand for cataract surgeries are positively influencing the market. Apart from this, the improving healthcare infrastructure and inflating disposable incomes are catalyzing the market. Moreover, the key players are investing in research and development to introduce innovative OVD products with improved safety and efficacy profiles, further driving the market growth. Besides, the increasing government initiatives to control visual impairment are propelling the market. Additionally, the rapid technological advancements in Ophthalmic Viscoelastic Devices (OVD) are expected to create a positive outlook for the market.

Key Market Segmentation:

Competitive Landscape with Key Players:

  • Alcon Inc.
  • Altacor Limited
  • Bausch Health Companies Inc.
  • Bohus Biotech Ab
  • Carl Zeiss Meditec Ag
  • Cima Technology Inc
  • Eyekon Medical Inc.
  • Johnson & Johnson
  • RUMEX International Co.

Product Insights:

  • Cohesive Ophthalmic Viscoelastic
  • Dispersive Ophthalmic Viscoelastic

Application Insights:

  • Cataract Surgery
  • Glaucoma Surgery
  • Corneal Transplant
  • Vitreoretinal Surgery

End User Insights:

  • Hospitals
  • Ophthalmic Clinics
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

  • Market Performance 
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Who we are:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Read More: https://recifest.com/